An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

The American Academy of Pediatrics said aggressive obesity interventions would not fuel eating disorders. But authors of the ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

Doctors’ protests in India have reframed a terrible case of violence against women into something else entirely, writes Kiran ...

Every year, hundreds of studies use an outdated, inhumane test on mice to try to find new antidepressants. Why is it still ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

A targeted immunotherapy being developed by iTeos Therapeutics and GSK, it was reported at #ESMO, delivered promising ...

One of the big presentations of this year’s ESMO (at least in our view) comes tomorrow morning bright and early. David Spigel ...

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...